Showing results (1081-1090 of 2,673) with videos related to

Sort By:
Pageof 268
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
The various therapeutic applications of the medical isotope holmium-166: a narrative reviewNienke J M Klaassen, Mark J Arntz, Alexandra Gil Arranja, et al.
Nurse Education Today|May 16, 2017
The Knowledge-about-Older-Patients - Quiz (KOP-Q) for nurses: Cross-cultural validation between the Netherlands and United States of AmericaJeroen Dikken, Jita G Hoogerduijn, Sharon Klaassen, et al.
Cardiovascular Research|September 1, 1988
Myocardial enzyme depletion in infarcted human hearts: infarct size and equivalent tissue massF H van der Veen, R Visser, G M Willems, et al.
BJU International|January 29, 2023
Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysisCarlos Riveros, Emily Huang, Sanjana Ranganathan, et al.
British Journal of Pharmacology|February 12, 1998
Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cellsM W Beukers, C H Klaassen, W J De Grip, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 28, 2007
The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activatorsErik K Pacyniak, Xingguo Cheng, Michael L Cunningham, et al.
Journal of Clinical Microbiology|September 15, 2004
Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococciChris Neeleman, Corné H W Klaassen, Debbie M Klomberg, et al.
Current Opinion in Supportive and Palliative Care|October 26, 2021
Cachexia and bladder cancer: clinical impact and managementSoum D Lokeshwar, Benjamin H Press, James Nie, et al.
Movement Ecology|February 1, 2022
Differences in on-ground and aloft conditions explain seasonally different migration paths in Demoiselle craneBatbayar Galtbalt, Nyambayar Batbayar, Tuvshintugs Sukhbaatar, et al.
Cancer Treatment Reports|May 1, 1985
Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustineH O Douglass, J M MacIntyre, J Kaufman, et al.
Pageof 268